For the Inventor, By the Inventor

Enter inventor name

Shanghai, China

Zheng Wang

USPTO Granted Patents = 42 (Patent Applications = 31)

EPO Patents = 18 (Patent Applications = 39)

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 40(Granted Patents)

Company Filing History:

Chinese Academy of Sciences

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

Yangtze River Pharmaceutical Group Co., Ltd.

4. 5 out of 118

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

5. 4 out of 599

Delta Electronics (shanghai) Co., Ltd

Shandong Danhong Pharmaceutical Co., Ltd.

Shanghai Dalong Technology Co., Ltd.

8. 2 out of 390

Business Objects Software Limited

Hubei Bio-pharmaceutical Industrial Technological Institute Inc.

Humanwell Healthcare (group) Co., Ltd.

11. 1 out of 11

Qilu Pharmaceutical Co., Ltd.

12. 1 out of 672

General Electric Technology Gmbh

13. 1 out of 13

Guangdong Raynovent Biotech Co., Ltd.

14. 1 out of 39,228

Fujitsu Corporation

Shanghai Bao Pharmaceuticals Co., Ltd.

Fujian Akeylink Biotechnology Co., Ltd.

Harbin Pharmaceutical Group Co., Ltd. General Pharmaceutical Factory

Shanghai Greencarbon Hi-tech Co., Ltd.

19. 1 out of 1,508

Shanghai Chemrun Co. Ltd.

21. 1 out of 170

Shanghai Avic Opto Electronics Co., Ltd.

22. 1 out of 680

Tianma Micro-electronics Co., Ltd.

23. 1 out of 372

On-bright Electronics (shanghai) Co., Ltd.

Guangzhou Joyo Pharmatech Co., Ltd.

25. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2015-2025

where 'Filed Patents' based on already Granted Patents

42 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12469601 - Method and system for individualized prediction of mental illness on basis of brain function map monkey-human cross-species migration (2025-11-11),

2. 12458647 - Macrocyclic derivative and use thereof (2025-11-04),

3. 12438381 - Systems and methods for power sharing related to multiport chargers (2025-10-07),

4. 12319942 - Use of mutant of immunoglobulin degrading enzyme IdeE (2025-06-03),

5. D1059400 - Display screen or portion thereof with animated graphical user interface (2025-01-28),

6. 12116367 - Ring-modified proline short peptide compound and use thereof (2024-10-15),

7. 11907741 - Virtual input device-based method and system for remotely controlling PC (2024-02-20),

8. 11325875 - Compound having chiral spirobiindane skeleton and preparation method therefor (2022-05-10),

9. 11124506 - Salts and crystal forms of diaza-benzofluoranthrene compounds (2021-09-21),

10. 10947245 - Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine for inhibiting toll-like receptor activity (2021-03-16),

11. 10947202 - Sodium ion channel inhibitors and pharmaceutically acceptable salts and polymorphs thereof and uses thereof (2021-03-16),

12. 10941150 - Salt type and crystal type of 4h-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof (2021-03-09),

13. 10912775 - Crystal form of orexin receptor antagonist compound, and preparation method and application thereof (2021-02-09),

14. 10898486 - Crystal form of orexin receptor antagonist compound, and preparation method and application thereof (2021-01-26),

15. 10874674 - Crystal form of orexin receptor antagonist compound, and preparation method and application thereof (2020-12-29),

Title: Innovator Profile: Zheng Wang

Introduction: Zheng Wang is a prominent inventor based in Shanghai, China, known for his significant contributions to various fields through his innovative work. With an impressive portfolio of 38 patents, he continues to make a mark in the pharmaceutical and technology industries.

Latest Patents: Zheng Wang's recent patents highlight his versatility and creativity. His notable patents include a "Display screen or portion thereof with animated graphical user interface," which showcases advancements in user interface design. Additionally, he has developed a "Ring-modified proline short peptide compound and use thereof," focusing on a compound represented by a specific formula, aimed at pharmaceutical applications.

Career Highlights: Throughout his career, Zheng has worked with reputable companies, notably Shanghai Haiyan Pharmaceutical Technology Co., Ltd. and Yangtze River Pharmaceutical Group Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the pharmaceutical sector.

Collaborations: Zheng Wang has collaborated with talented individuals such as Weidong Li and Haiying He. These professional partnerships have significantly enhanced his ability to innovate and develop impactful patents, demonstrating the importance of teamwork in the pursuit of technological advancement.

Conclusion: Zheng Wang stands out as an influential inventor whose work continues to shape the landscape of technology and pharmaceuticals. With a robust portfolio of patents and a commitment to innovation, he is poised to make further contributions that will benefit various industries.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…